By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Protein analytics firm BioScale said today it has raised $25 million in a recent financing round, to be used to commercialize the company's technology.

The round was led by new investor Morningside Venture, as well as existing investors New Science Ventures, WFD Ventures, F2 Ventures, and several individual investors.

BioScale will use the funds to expand manufacturing operations and sales of its ViBE protein analytics systems, the company said in a statement.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, Phys.org says.

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.

Oct
10
Sponsored by
PerkinElmer

This online, interactive seminar will answer researchers’ most pressing questions about how to gain outstanding research results from proteomic studies.